Stay updated on Lanadelumab for Pediatric HAE Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.

Latest updates to the Lanadelumab for Pediatric HAE Attacks Clinical Trial page
- CheckyesterdayChange DetectedThe record history shows the addition of revision 3.5.0 and the deletion of revision 3.4.3. These are metadata changes to the revision log and do not alter study details or eligibility.SummaryDifference0.1%

- Check8 days agoChange DetectedThe record history now lists an added entry for Revision: v3.4.3 and a deleted entry for Revision: v3.4.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedA new revision entry (v3.4.2) was added and the prior notices about government funding and operating status were removed, reflecting minor site-wide text updates to banners and version labeling. No impact on study data, outcomes, or core page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check44 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with links to cc.nih.gov and opm.gov for updates. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.8%

- Check51 days agoChange DetectedThe history page now includes a 'Show glossary' option, color-coded additions and deletions, and a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check65 days agoChange DetectedNew page revision label v3.3.4 was added and the previous v3.3.3 label removed; this is a minor UI update with no impact on study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab for Pediatric HAE Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.